OXiGENE (OXGN) to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum Conference on October 8, 2013
10/1/2013 9:25:52 AM
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2013 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that Peter Langecker, M.D., Ph.D., President and Chief Executive Officer, will provide a corporate overview at the 12th Annual BIO Investor Forum conference on October 8, 2013 at 4:00 PT at the Palace Hotel, San Francisco, California.
Help employers find you! Check out all the jobs and post your resume.